Molecular epidemiology of erythropoietic protoporphyria in the U.K.

British Journal of Dermatology

Volumn 162, Issue 3, 2010, Pages 642-646

  Whatley, S D ^a   Mason, N G ^a   Holme, S A ^a   Anstey, A V ^a   Elder, G H ^a   Badminton, M N ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

ALAS2; Erythropoietic protoporphyria; Ferrochelatase; Mutations

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; FERROCHELATASE; GENOMIC DNA;

ALAS2 GENE; ALLELE; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CORRELATION ANALYSIS; ERYTHROPOIETIC PROTOPORPHYRIA; FECH GENE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MOLECULAR EPIDEMIOLOGY; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; UNITED KINGDOM; X CHROMOSOME LINKED DISORDER; CROSS-SECTIONAL STUDY; DNA SEQUENCE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MUTATION; PEDIGREE; PROCEDURES; PROTOPORPHYRIA, ERYTHROPOIETIC; STATISTICS;

5-AMINOLEVULINATE SYNTHETASE; CROSS-SECTIONAL STUDIES; DNA MUTATIONAL ANALYSIS; FERROCHELATASE; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; MUTATION; PEDIGREE; PREVALENCE; PROTOPORPHYRIA, ERYTHROPOIETIC; SEQUENCE ANALYSIS, DNA; STATISTICS AS TOPIC;

EID: 76949097527     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09631.x     Document Type: Article

References (23)

1. Todd DJ. Erythropoietic protoporphyria. Br J Dermatol 1994 131 : 751 766.
2. Cox TM. Protoporphyria. In : The Porphyrin Handbook (Kadish KM, Smith KM, Guilard R, eds). Amsterdam : Academic Press, 2003 121 150.
3. Holme SA, Anstey AV, Finlay AY et al. Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. Br J Dermatol 2006 155 : 574 581.
4. Gouya L, Puy H, Robreau AM et al. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Nat Genet 2002 30 : 27 8.
5. Whatley SD, Mason NG, Khan M et al. Autosomal recessive erythropoietic protoporphyria in the United Kingdom: prevalence and relationship to liver disease. J Med Genet 2004 41 : e105.
6. Gouya L, Martin-Schmitt C, Robreau A-M et al. Contribution of a single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria. Am J Hum Genet 2006 78 : 2 14.
7. Whatley SD, Ducamp S, Gouya L et al. C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet 2008 83 : 408 414.
8. Schneider-Yin X, Mamet R, Minder EI, Schoenfeld N. Biochemical and molecular diagnosis of erythropoietic protoporphyria in an Ashkenazi Jewish family. J Inherit Metab Dis 2008 Aug 31 [Epub].
9. Parker M, Corrigall AV, Hift RJ, Meissner PN. Molecular characterization of erythropoietic protoporphyria in South Africa. Br J Dermatol 2008 159 : 182 191.
10. Schneider-Yin X, Harms J, Minder EI. Porphyria in Switzerland, 15 years experience. Swiss Med Wkly 2009 139 : 198 206.
11. Holme SA, Whatley SD, Roberts AG et al. Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritance. J Invest Dermatol 2009 129 : 599 605.
12. Whatley SD, Mason NG, Holme SA et al. Gene dosage analysis identifies large deletions of the FECH gene in 10% of families with erythropoietic protoporphyria. J Invest Dermatol 2007 127 : 2790 2794.
13. Deacon AC, Elder GH. Front line tests for the investigation of suspected porphyria. J Clin Pathol 2001 54 : 500 507.
14. Berroeta L, Man I, Goudie DR et al. Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members. Br J Dermatol 2007 157 : 1030 1031.
15. Rüfenacht UB, Gouya L, Schneider-Yin X et al. Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria. Am J Hum Genet 1998 62 : 1341 1352. (Pubitemid 28307103)
16. Wiman A, Floderus Y, Harper P. Novel mutations and phenotypic effect of the splice site modulator IVS3-48C in nine Swedish families with erythropoietic protoporphyria. J Hum Genet 2003 48 : 70 6.
17. Risheg H, Chen FP, Bloomer JR. Genotypic determinants of phenotype in North American patients with erythropoietic protoporphyria. Mol Genet Metab 2003 80 : 196 206.
18. Saruwatari H, Ueki Y, Yotsumoto S et al. Genetic analysis of the ferrochelatase gene in eight Japanese patients from seven families with erythropoietic protoporphyria. J Dermatol 2006 33 : 603 608.
19. Aurizi C, Schneider-Yin X, Sorge F et al. Heterogeneity of mutations in the ferrochelatase gene in Italian patients with erythropoietic protoporphyria. Mol Genet Metab 2007 90 : 402 407.
20. Herrero C, To-Figueras J, Badenas C et al. Clinical, biochemical, and genetic study of 11 patients with erythropoietic protoporphyria including one with homozygous disease. Arch Dermatol 2007 143 : 1125 1129.
21. Whatley SD, Mason NG, Woolf JR et al. Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene. Clin Chem 2009 55 : 1406 1414.
22. Todd DJ, Hughes AE, Ennis KT et al. Identification of a single base pair deletion (40 del G) in exon 1 of the ferrochelatase gene in patients with erythropoietic protoporphyria. Hum Mol Genet 1993 2 : 1495 1496.
23. Schneider-Yin X, Gouya L, Dorsey M et al. Mutations in the iron-sulfur cluster ligands of the human ferrochelatase lead to erythropoietic protoporphyria. Blood 2000 96 : 1545 1549.